Investment Research & Advisory Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
ECSS
CIM
ATO
Investment Research & Advisory Group's GILD Position: Q2 2026 in Review
Investment Research & Advisory Group increased its Gilead Sciences (GILD) stake by 0.49% in Q2 2026, buying an estimated $264 and bringing the position to 410 shares worth $55.2K. The position accounts for 0.02% of the portfolio, ranked #130.
Investment Research & Advisory Group first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $67.9K in Q1 2026. 911 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Investment Research & Advisory Group held 410 shares of Gilead Sciences worth $55.2K as of Q2 2026.
- Investment Research & Advisory Group bought 2 Gilead Sciences shares in Q2 2026, an estimated $264.
- Gilead Sciences made up 0.02% of Investment Research & Advisory Group's portfolio in Q2 2026, its #130 holding.
- Investment Research & Advisory Group first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
- Investment Research & Advisory Group's Gilead Sciences position peaked at $67.9K in Q1 2026.
- 911 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Investment Research & Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.